SLNO - Soleno Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

SLNO is currently covered by 5 analysts with an average price target of $66.54. This is a potential upside of $18.87 (39.58%) from yesterday's end of day stock price of $47.67.

Soleno Therapeutics's activity chart (see below) currently has 6 price targets and 21 ratings on display. The stock rating distribution of SLNO is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 66% with an average time for these price targets to be met of 78.4 days.

Highest price target for SLNO is $93, Lowest price target is $33, average price target is $66.54.

Most recent stock forecast was given by LELAND GERSHELL from OPPENHEIMER on 13-May-2024. First documented stock forecast 22-Jun-2018.

Best performing analysts who are covering SLNO - Soleno Therapeutics:

Kristen Kluska Debjit Chattopadhyay Leland Gershell Yale Jen Yasmeen Rahimi

Currently out of the existing stock ratings of SLNO, 15 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

59

$11.33 (23.77%)

47

2 months 1 days ago

8/10 (80%)

$16.2 (37.85%)

211

Buy

93

$45.33 (95.09%)

210

5 months 9 days ago

0/2 (0%)

$43.5 (87.88%)

Buy

44

$-3.67 (-7.70%)

40

6 months 23 days ago

2/2 (100%)

$7.14 (19.37%)

31

Buy

33

$-14.67 (-30.77%)

35

9 months 9 days ago

4/4 (100%)

$9.19 (38.60%)

60

Buy

39

$-8.67 (-18.19%)

9 months 17 days ago

1/2 (50%)

$18.33 (88.68%)

90

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SLNO (Soleno Therapeutics) average time for price targets to be met?

On average it took 78.4 days on average for the stock forecasts to be realized with a an average price target met ratio 66

Which analyst has the current highest performing score on SLNO (Soleno Therapeutics) with a proven track record?

KRISTEN KLUSKA

Which analyst has the current lower performing score on SLNO (Soleno Therapeutics) with a proven track record?

YASMEEN RAHIMI

Which analyst has the most public recommendations on SLNO (Soleno Therapeutics)?

Kristen Kluska works at CANTOR FITZGERALD and has 15 price targets and 12 ratings on SLNO

Which analyst is the currently most bullish on SLNO (Soleno Therapeutics)?

Yasmeen Rahimi with highest potential upside - $45.33

Which analyst is the currently most reserved on SLNO (Soleno Therapeutics)?

Kristen Kluska with lowest potential downside - -$14.67

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?